These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28643818)

  • 1. Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.
    Brigant B; Metzinger-Le Meuth V; Massy ZA; McKay N; Liabeuf S; Pelletier M; Sallée M; M'Baya-Moutoula E; Paul P; Drueke TB; Burtey S; Metzinger L
    Clin Kidney J; 2017 Feb; 10(1):30-37. PubMed ID: 28643818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Are Associated with Uremic Toxicity, Cardiovascular Calcification, and Disease.
    Massy ZA; Metzinger-Le Meuth V; Metzinger L
    Contrib Nephrol; 2017; 189():160-168. PubMed ID: 27951581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA biomarkers in renal disease.
    Franczyk B; Gluba-Brzózka A; Olszewski R; Parolczyk M; Rysz-Górzyńska M; Rysz J
    Int Urol Nephrol; 2022 Mar; 54(3):575-588. PubMed ID: 34228259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction.
    Zununi Vahed S; Poursadegh Zonouzi A; Mahmoodpoor F; Samadi N; Ardalan M; Omidi Y
    Arch Med Res; 2017 Jan; 48(1):96-104. PubMed ID: 28577875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.
    Fourdinier O; Schepers E; Metzinger-Le Meuth V; Glorieux G; Liabeuf S; Verbeke F; Vanholder R; Brigant B; Pletinck A; Diouf M; Burtey S; Choukroun G; Massy ZA; Metzinger L;
    Sci Rep; 2019 Mar; 9(1):4477. PubMed ID: 30872798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122.
    Rivoli L; Vliegenthart AD; de Potter CM; van Bragt JJ; Tzoumas N; Gallacher P; Farrah TE; Dhaun N; Dear JW
    Br J Clin Pharmacol; 2017 Mar; 83(3):584-592. PubMed ID: 27650800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired vascular function contributes to exercise intolerance in chronic kidney disease.
    Van Craenenbroeck AH; Van Craenenbroeck EM; Van Ackeren K; Hoymans VY; Verpooten GA; Vrints CJ; Couttenye MM
    Nephrol Dial Transplant; 2016 Dec; 31(12):2064-2072. PubMed ID: 27540045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.
    Van Craenenbroeck AH; Ledeganck KJ; Van Ackeren K; Jürgens A; Hoymans VY; Fransen E; Adams V; De Winter BY; Verpooten GA; Vrints CJ; Couttenye MM; Van Craenenbroeck EM
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2008-16. PubMed ID: 26475583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
    Zununi Vahed S; Omidi Y; Ardalan M; Samadi N
    Clin Biochem; 2017 Jan; 50(1-2):32-39. PubMed ID: 27521993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD).
    Chen NX; Kiattisunthorn K; O'Neill KD; Chen X; Moorthi RN; Gattone VH; Allen MR; Moe SM
    PLoS One; 2013; 8(5):e64558. PubMed ID: 23717629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Omidi Y; Ardalan M
    Int Urol Nephrol; 2017 Sep; 49(9):1681-1689. PubMed ID: 28455659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy.
    Pivarcsi A; Meisgen F; Xu N; Ståhle M; Sonkoly E
    Br J Dermatol; 2013 Sep; 169(3):563-70. PubMed ID: 23600954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular microRNA signature in chronic kidney disease.
    Muralidharan J; Ramezani A; Hubal M; Knoblach S; Shrivastav S; Karandish S; Scott R; Maxwell N; Ozturk S; Beddhu S; Kopp JB; Raj DS
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F982-F991. PubMed ID: 28077372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients.
    Lange T; Stracke S; Rettig R; Lendeckel U; Kuhn J; Schlüter R; Rippe V; Endlich K; Endlich N
    PLoS One; 2017; 12(8):e0183435. PubMed ID: 28859135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.
    Tay JW; James I; Hughes QW; Tiao JY; Baker RI
    BMC Res Notes; 2017 Jul; 10(1):312. PubMed ID: 28743297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
    Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
    Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease.
    Taïbi F; Metzinger-Le Meuth V; M'Baya-Moutoula E; Djelouat Ms; Louvet L; Bugnicourt JM; Poirot S; Bengrine A; Chillon JM; Massy ZA; Metzinger L
    Biochim Biophys Acta; 2014 Jan; 1842(1):88-98. PubMed ID: 24140891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.